These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8382468)

  • 1. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment.
    Sitzmann JV; Abrams R
    Ann Surg; 1993 Feb; 217(2):149-54. PubMed ID: 8382468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage surgery following downstaging of unresectable hepatocellular carcinoma.
    Lau WY; Ho SK; Yu SC; Lai EC; Liew CT; Leung TW
    Ann Surg; 2004 Aug; 240(2):299-305. PubMed ID: 15273555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.
    Order S; Pajak T; Leibel S; Asbell S; Leichner P; Ettinger D; Stillwagon G; Herpst J; Haulk T; Kopher K
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):953-63. PubMed ID: 1850722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01.
    Stillwagon GB; Order SE; Guse C; Leibel SA; Asbell SO; Klein JL; Leichner PK
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):65-71. PubMed ID: 1847127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
    Li KD
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma.
    Ku Y; Iwasaki T; Tominaga M; Fukumoto T; Takahashi T; Kido M; Ogata S; Takahashi M; Kuroda Y; Matsumoto S; Obara H
    Ann Surg; 2004 Jan; 239(1):53-60. PubMed ID: 14685100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
    J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three decades' experience in surgery of hepatocellular carcinoma.
    Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.
    King DR; Ortega J; Campbell J; Haas J; Ablin A; Lloyd D; Newman K; Quinn J; Krailo M; Feusner J
    J Pediatr Surg; 1991 Sep; 26(9):1074-80; discussion 1080-1. PubMed ID: 1658289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s.
    Tang ZY; Yu YQ; Zhou XD
    Semin Surg Oncol; 1993; 9(4):293-7. PubMed ID: 7692581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Debulking surgery and arterial embolization for unresectable liver cancer.
    Shimamura Y; Gunvén P; Ishii M; Ono M; Abe K
    Hepatogastroenterology; 1993 Feb; 40(1):10-3. PubMed ID: 8385063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
    Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
    Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.